Cheng Yuan

8PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTissue engineeringHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 27, 2026
Mitophagy in cisplatin-induced kidney injury: regulatory mechanisms and therapeutic targets.

|Mar 15, 2026
UBE2M Identified by CRISPR Screening as a Key Regulator of Cisplatin-Induced Acute Kidney Injury via the p53 Pathway

Cheng Yuan, Feng Chen, Xueyun Gao

|Dec 23, 2025
Identification of Glutathione Synthetase as a Therapeutic Target for Cervical Cancer via Combining Bioinformatics and Experimental Validation.

Meini Pan, Tingzhuang Yi, Peng Lei

|Jul 24, 2025
EphrinB2 alleviates tubulointerstitial fibrosis in diabetic kidney disease.

Lihua Ni, Qiuyuan Zhou, Xueyun Gao

|Feb 25, 2022
Targeting ferroptosis in acute kidney injury.

Lihua Ni, Cheng Yuan, Xiaoyan Wu

|Dec 20, 2021
Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells via Targeting HOXA10.

Cheng Yuan, Rui Bai, Yanping Gao

Pageof 2

Frequent Collaborators

5 joint publications

Lihua Ni

2 joint publications

Xiaoyan Wu

1 joint publications

Yan Gong

1 joint publications

Conghua Xie